Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Neoplasms 2Motor Activity 2Lymphoma 2Anxiety Disorders 2Weight Gain 1Vomiting 1Triple Negative Breast Neoplasms 1Treatment Adherence and Compliance 1Recurrence 1Obesity 1Nausea 1Lymphoma, Large B-Cell, Diffuse 1Lymphedema 1Gastrointestinal Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Weights and Measures × Clear all
NCT02750358 2025-06-22

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
50 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06324721 2025-01-29

LymphSens

Universitaire Ziekenhuizen KU Leuven

Phase NA Recruiting
230 enrolled
Breast

Breast Neoplasms, Lymphedema

NCT03262831 2019-09-03

Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer

Washington University School of Medicine

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡